<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Pharmacological interventions for the acute management of hyperkalaemia in adults - Batterink, J - 2015 | Cochrane Library</title> <meta content="Pharmacological interventions for the acute management of hyperkalaemia in adults - Batterink, J - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010344.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Pharmacological interventions for the acute management of hyperkalaemia in adults - Batterink, J - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010344.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD010344.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Pharmacological interventions for the acute management of hyperkalaemia in adults" name="citation_title"/> <meta content="Josh Batterink" name="citation_author"/> <meta content="Providence Health Care" name="citation_author_institution"/> <meta content="batterinkj@gmail.com" name="citation_author_email"/> <meta content="Tara A Cessford" name="citation_author"/> <meta content="University of British Columbia" name="citation_author_institution"/> <meta content="Robert AI Taylor" name="citation_author"/> <meta content="Providence Health Care" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="10" name="citation_issue"/> <meta content="10.1002/14651858.CD010344.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/10/27" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010344.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010344.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010344.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD010344.pub2&amp;doi=10.1002/14651858.CD010344.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774054000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739774081000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1559916434000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1559916434000"}};Liferay.authToken="uYcNEb5O";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD010344\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD010344\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1559916434000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD010344.pub2",title:"Pharmacological interventions for the acute management of hyperkalaemia in adults",firstPublishedDate:"Oct 27, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Kidney and Transplant Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738735355000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010344.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010344.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD010344.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD010344.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010344.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD010344.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD010344.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD010344.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD010344.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD010344.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6937 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD010344.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-sec-0075"> Authors' conclusions </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-sec-0015"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-sec-0019"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-sec-0020"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-sec-0045"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-sec-0069"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/appendices#CD010344-sec-0080"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/table_n/CD010344StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/table_n/CD010344StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Pharmacological interventions for the acute management of hyperkalaemia in adults</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information#CD010344-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Josh Batterink</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information#CD010344-cr-0003">Tara A Cessford</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information#CD010344-cr-0004">Robert AI Taylor</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information/en#CD010344-sec-0085">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 27 October 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD010344.pub2">https://doi.org/10.1002/14651858.CD010344.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD010344-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010344-abs-0006">فارسی</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD010344-abs-0001" lang="en"> <section id="CD010344-sec-0001"> <h3 class="title" id="CD010344-sec-0001">Background</h3> <p>Hyperkalaemia is a potentially life‐threatening electrolyte disturbance which may lead to cardiac arrhythmias and death. Renal replacement therapy is known to be effective in treating hyperkalaemia, but safe and effective pharmacological interventions are needed to prevent dialysis or avoid the complications of hyperkalaemia until dialysis is performed. </p> </section> <section id="CD010344-sec-0002"> <h3 class="title" id="CD010344-sec-0002">Objectives</h3> <p>This review looked at the benefits and harms of pharmacological treatments used in the acute management of hyperkalaemia in adults. This review evaluated the therapies that reduce serum potassium as well as those that prevent complications of hyperkalaemia. </p> </section> <section id="CD010344-sec-0003"> <h3 class="title" id="CD010344-sec-0003">Search methods</h3> <p>We searched Cochrane Kidney and Transplant's Specialised Register to 18 August 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. </p> </section> <section id="CD010344-sec-0004"> <h3 class="title" id="CD010344-sec-0004">Selection criteria</h3> <p>All randomised controlled trials (RCTs) and quasi‐RCTs looking at any pharmacological intervention for the acute management of hyperkalaemia in adults were included in this review. Non‐standard study designs such as cross‐over studies were also included. Eligible studies enrolled adults (aged 18 years and over) with hyperkalaemia, defined as serum potassium concentration ≥ 4.9 mmol/L, to receive pharmacological therapy to reduce serum potassium or to prevent arrhythmias. Patients with artificially induced hyperkalaemia were excluded from this review. </p> </section> <section id="CD010344-sec-0005"> <h3 class="title" id="CD010344-sec-0005">Data collection and analysis</h3> <p>All three authors screened titles and abstracts, and data extraction and risk of bias assessment was performed independently by at least two authors. Studies reported in non‐English language journals were translated before assessment. Authors were contacted when information about results or study methodology was missing from the original publication. Although we planned to group all studies of a particular pharmacological therapy regardless of administration route or dose for analysis, we were unable to conduct meta‐analyses because of the small numbers of studies evaluating any given treatment. For continuous data we reported mean difference (MD) and 95% confidence intervals (CI). </p> </section> <section id="CD010344-sec-0006"> <h3 class="title" id="CD010344-sec-0006">Main results</h3> <p>We included seven studies (241 participants) in this review. Meta‐analysis of these seven included studies was not possible due to heterogeneity of the treatments and because many of the studies did not provide sufficient statistical information with their results. Allocation and blinding methodology was poorly described in most studies. </p> <p>No study evaluated the efficacy of pharmacological interventions for preventing clinically relevant outcomes such as mortality and cardiac arrhythmias; however there is evidence that several commonly used therapies effectively reduce serum potassium levels. Salbutamol administered via either nebulizer or metered‐dose inhaler (MDI) significantly reduced serum potassium compared with placebo. The peak effect of 10 mg nebulised salbutamol was seen at 120 minutes (MD ‐1.29 mmol/L, 95% CI ‐1.64 to ‐0.94) and at 90 minutes for 20 mg nebulised salbutamol (1 study: MD ‐1.18 mmol/L, 95% CI ‐1.54 to ‐0.82). One study reported 1.2 mg salbutamol via MDI 1.2 mg produced a significant decrease in serum potassium beginning at 10 minutes (MD ‐0.20 mmol/L, P &lt; 0.05) and a maximal decrease at 60 minutes (MD ‐0.34 mmol/L, P &lt; 0.0001). Intravenous (IV) and nebulised salbutamol produced comparable effects (2 studies). When compared to other interventions, salbutamol had similar effect to insulin‐dextrose (2 studies) but was more effective than bicarbonate at 60 minutes (MD ‐0.46 mmol/L, 95% CI ‐0.82 to ‐0.10; 1 study). Insulin‐dextrose was more effective than IV bicarbonate (1 study) and aminophylline (1 study). Insulin‐dextrose, bicarbonate and aminophylline were not studied in any placebo‐controlled studies. None of the included studies evaluated the effect of IV calcium or potassium binding resins in the treatment of hyperkalaemia. </p> </section> <section id="CD010344-sec-0007"> <h3 class="title" id="CD010344-sec-0007">Authors' conclusions</h3> <p>Evidence for the acute pharmacological management of hyperkalaemia is limited, with no clinical studies demonstrating a reduction in adverse patient outcomes. Of the studied agents, salbutamol via any route and IV insulin‐dextrose appear to be most effective at reducing serum potassium. There is limited evidence to support the use of other interventions, such as IV sodium bicarbonate or aminophylline. The effectiveness of potassium binding resins and IV calcium salts has not been tested in RCTs and requires further study before firm recommendations for clinical practice can be made. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD010344-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-abs-0005">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD010344-abs-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD010344-abs-0004">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD010344-abs-0003" lang="en"> <h3>Pharmacological interventions for the acute management of hyperkalaemia in adults</h3> <p>Hyperkalaemia is a serious medical problem that may cause heart problems or death. There are several treatments that can be used to treat hyperkalaemia but the risks and benefits of each intervention are poorly understood. We performed this review to determine whether treatments for hyperkalaemia are effective and safe </p> <p>We searched for all studies that tested whether therapies were effective and safe at treating high potassium published up to 18 August 2015. We found seven studies that investigated drug therapies for treating hyperkalaemia in adults which together included results from 241 participants. Most studies tested the therapies in male and female adults with kidney problems who were medically stable. We did not find any studies that looked at the serious medical complications of high potassium such as death. </p> <p>We found that salbutamol and insulin‐dextrose were effective in reducing potassium levels in the blood. We found that salbutamol was effective whether it was given intravenously or by nebuliser. Those treatments appeared to be more effective than other treatments such as sodium bicarbonate and aminophylline. None of the studies found any serious adverse reactions to the medications. </p> <p>Overall, the quality of evidence was assessed as poor because the studies were small in size and the methods for how the studies were performed were not well described. None of the studies looked at the serious problems caused by hyperkalaemia and this limited the strength of the evidence. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD010344-sec-0075" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-sec-0075">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-sec-0110">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD010344-sec-0075"></div> <h3 class="title" id="CD010344-sec-0076">Implications for practice</h3> <section id="CD010344-sec-0076"> <p>Salbutamol given via nebuliser, MDI or IV produces a statistically significant reduction in serum potassium, but there are no clinical studies demonstrating a reduction in adverse patient outcomes. IV insulin‐dextrose appears to be as effective as salbutamol at reducing serum potassium. Despite a lack of more robust evidence of clinical benefit from highly powered RCTs, the reduction in serum potassium achieved with salbutamol or IV insulin‐dextrose is of conceivable clinical relevance, thus we support the continued use of these agents as first line therapy in the acute management of hyperkalaemia. This is in accordance with current clinical practice guidelines and reviews (<a href="./references#CD010344-bbs2-0033" title="AlfonzoA , SoarJ , MacTierR , FoxJ , ShillidayI , NolanJ , et al. Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2014. www.renal.org/docs/default‐source/guidelines‐resources/joint‐guidelines/treatment‐of‐acute‐hyperkalaemia‐in‐adults/hyperkalaemia‐guideline‐‐‐march‐2014.pdf?sfvrsn=2 (accessed 14 September 2015). ">Alfonzo 2014</a>; <a href="./references#CD010344-bbs2-0043" title="Hollander‐RodriguezJC , CalvertJFJr . Hyperkalemia. American Family Physician2006;73(2):283‐90. [MEDLINE: 16445274] ">Hollander‐Rodriguez 2006</a>; <a href="./references#CD010344-bbs2-0046" title="McVeighG , MaxwellP , O'DonnellS . Guidelines for the treatment of hyperkalemia in adults. Guidelines and Audit Implementation Network, 2014. www.gain‐ni.org/images/Uploads/Guidelines/GAIN_Guidelines_Treatment_of_Hyperkalaemia_in_Adults_GAIN_02_12_2014.pdf (accessed 14 September 2015). ">McVeigh 2014</a>). </p> <p>IV sodium bicarbonate appears less effective than either salbutamol or insulin‐dextrose. In the absence of severe acidosis, we feel there is insufficient evidence to justify the routine use of bicarbonate in the acute management of hyperkalaemia. Aminophylline appears less effective than insulin‐dextrose. </p> <p>The combination of IV insulin‐dextrose with salbutamol is more effective than either therapy alone and may be useful in the setting of severe hyperkalaemia. Triple therapy with insulin‐dextrose, salbutamol and bicarbonate was not significantly better than dual therapy. </p> <p>There were no RCTs found evaluating IV calcium for the treatment of hyperkalaemia; however, withholding this therapy in patients with severe hyperkalaemia or ECG changes or both given the potentially life‐threatening consequences is not advised. </p> <p>There are no RCTs evaluating potassium‐binding resins (e.g. sodium polystyrene sulphonate) therefore we cannot comment on their use at this time. Published clinical practice guidelines and reviews (<a href="./references#CD010344-bbs2-0033" title="AlfonzoA , SoarJ , MacTierR , FoxJ , ShillidayI , NolanJ , et al. Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2014. www.renal.org/docs/default‐source/guidelines‐resources/joint‐guidelines/treatment‐of‐acute‐hyperkalaemia‐in‐adults/hyperkalaemia‐guideline‐‐‐march‐2014.pdf?sfvrsn=2 (accessed 14 September 2015). ">Alfonzo 2014</a>; <a href="./references#CD010344-bbs2-0043" title="Hollander‐RodriguezJC , CalvertJFJr . Hyperkalemia. American Family Physician2006;73(2):283‐90. [MEDLINE: 16445274] ">Hollander‐Rodriguez 2006</a>; <a href="./references#CD010344-bbs2-0046" title="McVeighG , MaxwellP , O'DonnellS . Guidelines for the treatment of hyperkalemia in adults. Guidelines and Audit Implementation Network, 2014. www.gain‐ni.org/images/Uploads/Guidelines/GAIN_Guidelines_Treatment_of_Hyperkalaemia_in_Adults_GAIN_02_12_2014.pdf (accessed 14 September 2015). ">McVeigh 2014</a>) suggest using resins for mild to moderate hyperkalaemia. Only one clinical practice guideline (<a href="./references#CD010344-bbs2-0033" title="AlfonzoA , SoarJ , MacTierR , FoxJ , ShillidayI , NolanJ , et al. Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2014. www.renal.org/docs/default‐source/guidelines‐resources/joint‐guidelines/treatment‐of‐acute‐hyperkalaemia‐in‐adults/hyperkalaemia‐guideline‐‐‐march‐2014.pdf?sfvrsn=2 (accessed 14 September 2015). ">Alfonzo 2014</a>) comments on the lack of evidence for using resins. </p> </section> <h3 class="title" id="CD010344-sec-0077">Implications for research</h3> <section id="CD010344-sec-0077"> <p>Due to ethical concerns, we may never demonstrate in a RCT that acute management of hyperkalaemia reduces patient morbidity, mortality or both. </p> <p>Clinical studies should seek to identify novel agents with greater efficacy than our current treatment options, in terms of magnitude and rate of serum potassium reduction. Alternatively, studies might demonstrate that novel agents have a complimentary, adjunctive role in the tiered management of hyperkalaemia. Studies should ensure that novel agents produce non‐inferior or superior clinical outcomes such as arrhythmia or death when compared to standard treatment. </p> <p>Further studies are needed to confirm the efficacy of potassium binding resins in order to clarify their role in the tiered approach to therapy. </p> </section> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD010344-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-sec-0015">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-sec-0089">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD010344-sec-0015"></div> <section id="CD010344-sec-0016"> <h3 class="title" id="CD010344-sec-0016">Description of the condition</h3> <p>Hyperkalaemia is defined as an excess concentration of potassium ions in the extracellular fluid compartment. Hyperkalaemia occurs in both outpatients and hospitalised patients, often due to kidney failure, insulin deficiency, direct tissue trauma, or drugs and disorders that inhibit the renin‐angiotensin‐aldosterone axis. Patients with hyperkalaemia may experience muscle weakness, fatigue, distal paraesthesia and respiratory depression (<a href="./references#CD010344-bbs2-0039" title="FreemanSJ , FaleAD . Muscular paralysis and ventilatory failure caused by hyperkalaemia. British Journal of Anaesthesia1993;70(2):226‐7. [MEDLINE: 8435272] ">Freeman 1993</a>). The most feared consequence of hyperkalaemia is cardiac arrhythmias. Electrocardiogram (ECG) changes include peaked T waves, QRS widening and diminished P waves. Severe hyperkalaemia may lead to a sine wave ECG pattern, ventricular tachycardia, ventricular fibrillation and death (<a href="./references#CD010344-bbs2-0035" title="BrowningJJ , ChannerKS . Hyperkalaemic cardiac arrhythmia caused by potassium citrate mixture. British Medical Journal Clinical Research Ed1981;283(6303):1366. [MEDLINE: 6797547] ">Browning 1981</a>). The urgency of treatment varies with the cause, presence or absence of associated signs and symptoms, and the rate of rise in serum potassium. </p> </section> <section id="CD010344-sec-0017"> <h3 class="title" id="CD010344-sec-0017">Description of the intervention</h3> <p>The pharmacological management of hyperkalaemia is conventionally divided into three distinct tiers of therapy, each with a different mechanism of action (<a href="./references#CD010344-bbs2-0033" title="AlfonzoA , SoarJ , MacTierR , FoxJ , ShillidayI , NolanJ , et al. Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2014. www.renal.org/docs/default‐source/guidelines‐resources/joint‐guidelines/treatment‐of‐acute‐hyperkalaemia‐in‐adults/hyperkalaemia‐guideline‐‐‐march‐2014.pdf?sfvrsn=2 (accessed 14 September 2015). ">Alfonzo 2014</a>). Patients with severe hyperkalaemia, a serum potassium level ≥ 6.5 mmol/L with or without ECG changes (<a href="./references#CD010344-bbs2-0033" title="AlfonzoA , SoarJ , MacTierR , FoxJ , ShillidayI , NolanJ , et al. Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2014. www.renal.org/docs/default‐source/guidelines‐resources/joint‐guidelines/treatment‐of‐acute‐hyperkalaemia‐in‐adults/hyperkalaemia‐guideline‐‐‐march‐2014.pdf?sfvrsn=2 (accessed 14 September 2015). ">Alfonzo 2014</a>), first receive intravenous (IV) calcium salts to stabilize the cardiac membrane and prevent fatal arrhythmias even in the absence of any effect on serum potassium levels (<a href="./references#CD010344-bbs2-0040" title="GreenbergA . Hyperkalemia: treatment options. Seminars in Nephrology1998;18(1):46‐57. [MEDLINE: 9459288] ">Greenberg 1998</a>; <a href="./references#CD010344-bbs2-0048" title="SchwartzAB . Potassium‐related cardiac arrhythmias and their treatment. Angiology1978;29(3):194‐205. [MEDLINE: 646184] ">Schwartz 1978</a>). This affords the physician time to initiate second tier therapy, pharmacological agents that shift potassium from the extracellular to the intracellular space. IV bicarbonate lowers the serum hydrogen ion concentration, thereby promoting an intracellular shift of potassium ions in exchange for hydrogen. Beta‐2 agonists and insulin enhance the activity of the Na‐K‐ATPase pump in skeletal muscle and drive potassium intracellularly (<a href="./references#CD010344-bbs2-0049" title="WilliamsME , GervinoEV , RosaRM , LandsbergL , YoungJB , SilvaP , et al. Catecholamine modulation of rapid potassium shifts during exercise. New England Journal of Medicine1985;312(13):823‐7. [MEDLINE: 2858053] ">Williams 1985</a>; <a href="./references#CD010344-bbs2-0050" title="ZierlerK . Insulin hyperpolarizes rat myotube primary culture without stimulating glucose uptake. Diabetes1987;36(9):1035‐40. [MEDLINE: 3301473] ">Zierler 1987</a>). Finally, third tier therapy definitively treats the problem by eliminating potassium from the body. Diuretics may promote excretion of potassium into the urine and cation exchange resins are thought to bind potassium in the intestinal tract and remove it from the body via faecal excretion (<a href="./references#CD010344-bbs2-0034" title="BerlyneGM , JanabiK , ShawAB , HockenAG . Treatment of hyperkalemia with a calcium‐resin. Lancet1966;1(7420):169‐72. [MEDLINE: 4164888] ">Berlyne 1966</a>; <a href="./references#CD010344-bbs2-0044" title="JohnsonK , CazeeC , GutchC , OgdenD . Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients. Clinical Nephrology1976;5(6):266‐8. [MEDLINE: 1277599] ">Johnson 1976</a>). </p> <p>Dialysis effectively treats hyperkalaemia in patients with kidney impairment, but the evidence for renal replacement therapy (RRT) will not be discussed in detail in this review. The decision to initiate dialysis depends on the severity and aetiology of the hyperkalaemia, the safety and effectiveness of alternate therapies, as well as availability of dialysis (<a href="./references#CD010344-bbs2-0038" title="EvansKJ , GreenbergA . Hyperkalemia: a review. Journal of Intensive Care Medicine2005;20(5):272‐90. [MEDLINE: 16145218] ">Evans 2005</a>; <a href="./references#CD010344-bbs2-0047" title="PutchaN , AllonM . Management of hyperkalemia in dialysis patients. Seminars in Dialysis2007;20(5):431‐9. [MEDLINE: 17897250] ">Putcha 2007</a>). Pharmacological interventions are used to prevent the need for dialysis or to prevent complications until dialysis can be performed. In this review, the need for dialysis will be treated as an outcome rather than a treatment (<a href="./references#CD010344-bbs2-0036" title="CarvalhanaV , BurryL , LapinskySE . Management of severe hyperkalemia without hemodialysis: case report and literature review. Journal of Critical Care2006;21(4):316‐21. [MEDLINE: 17175417] ">Carvalhana 2006</a>). </p> <p>Although the evidence for RRT is outside the scope of this review, it is worth noting that dialysis is generally considered the definitive treatment for hyperkalaemia. Conventional haemodialysis causes the most rapid decrease in serum potassium levels. Other forms of dialysis (peritoneal dialysis, continuous venovenous haemofiltration or continuous venovenous haemodialysis) are also effective. The amount of potassium removed during dialysis depends on dialysis duration, dialysate potassium concentration, dialyser membrane, and patient characteristics such as baseline serum potassium (<a href="./references#CD010344-bbs2-0038" title="EvansKJ , GreenbergA . Hyperkalemia: a review. Journal of Intensive Care Medicine2005;20(5):272‐90. [MEDLINE: 16145218] ">Evans 2005</a>). </p> </section> <section id="CD010344-sec-0018"> <h3 class="title" id="CD010344-sec-0018">Why it is important to do this review</h3> <p>Hyperkalaemia is a commonly encountered, potentially life‐threatening clinical problem that requires prompt and effective treatment to prevent serious complications. This review summarises and synthesises the literature published on the acute pharmacological management of hyperkalaemia to help clinicians best treat their patients. This review is a derivative of a Cochrane systematic literature review first published in 2005 (<a href="./references#CD010344-bbs2-0037" title="MahoneyBA , SmithWA , LoD , TsoiK , TonelliM , ClaseC . Emergency interventions for hyperkalaemia. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD003235.pub2] ">Clase 2005</a>), but has narrowed the focus to the effectiveness and safety of the acute pharmacological management of hyperkalaemia in adults. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD010344-sec-0019" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-sec-0019">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-sec-0093">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD010344-sec-0019"></div> <p>This review looked at the benefits and harms of pharmacological treatments used in the acute management of hyperkalaemia in adults. This review evaluated the therapies that reduce serum potassium as well as those that prevent complications of hyperkalaemia. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD010344-sec-0020" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-sec-0020">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-sec-0094">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD010344-sec-0020"></div> <section id="CD010344-sec-0021"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD010344-sec-0022"> <h4 class="title">Types of studies</h4> <p>All randomised controlled trials (RCTs) and quasi‐RCTs (RCTs in which allocation to treatment was obtained by alternation, use of alternate medical records, date of birth or other predictable methods) looking at any pharmacological intervention for the acute management of hyperkalaemia in adults were included. Non‐standard study designs such as cross‐over studies were also included in the review. </p> </section> <section id="CD010344-sec-0023"> <h4 class="title">Types of participants</h4> <section id="CD010344-sec-0024"> <h5 class="title">Inclusion criteria</h5> <p>The study population of this review was adults (aged 18 years and over) with hyperkalaemia receiving pharmacological therapy to reduce serum potassium or to prevent arrhythmias. Hyperkalaemia was defined as serum potassium concentration ≥ 4.9 mmol/L. Studies were included when it was clear that the majority of study participants met this definition. Patients with a variety of causes of hyperkalaemia, including both acute and chronic kidney failure, were included in the study. </p> </section> <section id="CD010344-sec-0025"> <h5 class="title">Exclusion criteria</h5> <p>Patients with artificially induced hyperkalaemia were excluded from this review.</p> </section> </section> <section id="CD010344-sec-0026"> <h4 class="title">Types of interventions</h4> <p>All pharmacological therapies used in the short‐term management of hyperkalaemia were considered, including interventions used to reduce serum potassium as well as therapies used to prevent arrhythmias. </p> <p>Studies where interventions were compared with placebo or another pharmacological therapy were included. Studies comparing a pharmacological intervention with dialysis were not included. Studies were included regardless of the route of administration or dose of the pharmacological therapy. For the initial analysis, all studies of a particular pharmacological therapy, regardless of dose or route of administration, were analysed together. </p> <p>The source of a blood sample for potassium measurement (venous or arterial) can introduce additional variation (<a href="./references#CD010344-bbs2-0045" title="JohnstonHL , MurphyR . Agreement between an arterial blood gas analyser and a venous blood analyser in the measurement of potassium in patients in cardiac arrest. Emergency Medicine Journal2005;22(4):269‐71. [MEDLINE: 15788827] ">Johnston 2005</a>). Ideally, all studies would report potassium measurements from the same source, but if this was not the case, potassium levels were preferentially used from whichever source was more common. </p> </section> <section id="CD010344-sec-0027"> <h4 class="title">Types of outcome measures</h4> <p> <ol id="CD010344-list-0001"> <li> <p>Mortality</p> </li> <li> <p>Arrhythmias</p> </li> <li> <p>Dialysis</p> </li> <li> <p>Serum potassium</p> </li> <li> <p>ECG changes</p> </li> <li> <p>Adverse events.</p> </li> </ol> </p> <section id="CD010344-sec-0028"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD010344-list-0002"> <li> <p>Serum potassium</p> </li> <li> <p>Mortality</p> </li> <li> <p>Arrhythmias.</p> </li> </ul> </p> </section> <section id="CD010344-sec-0029"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD010344-list-0003"> <li> <p>Dialysis</p> </li> <li> <p>ECG changes</p> </li> <li> <p>Adverse events.</p> </li> </ul> </p> </section> </section> </section> <section id="CD010344-sec-0030"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD010344-sec-0031"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Kidney and Transplant's Specialised Register up to 18 August 2015 through contact with the Trials' Search Co‐ordinator using search terms relevant to this review. The Specialised Register contains studies identified from the following sources. </p> <p> <ol id="CD010344-list-0004"> <li> <p>Quarterly searches of the Cochrane Central Register of Controlled Trials CENTRAL</p> </li> <li> <p>Weekly searches of MEDLINE OVID SP</p> </li> <li> <p>Handsearching of kidney‐related journals and the proceedings of major kidney conferences</p> </li> <li> <p>Searching of the current year of EMBASE OVID SP</p> </li> <li> <p>Weekly current awareness alerts for selected kidney journals</p> </li> <li> <p>Searches of the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov.</p> </li> </ol> </p> <p>Studies contained in the Specialised Register were identified through search strategies for CENTRAL, MEDLINE, and EMBASE based on the scope of Cochrane Kidney and Transplant. Details of these strategies as well as a list of handsearched journals, conference proceedings and current awareness alerts are available in the Specialised Register section of information about the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/RENAL/frame.html" target="_blank">Cochrane Kidney and Transplant</a>. </p> <p>See <a href="./appendices#CD010344-sec-0081">Appendix 1</a> for search terms used in strategies for this review. </p> </section> <section id="CD010344-sec-0032"> <h4 class="title">Searching other resources</h4> <p> <ol id="CD010344-list-0005"> <li> <p>Reference lists of review articles, relevant studies and clinical practice guidelines.</p> </li> <li> <p>Letters to investigators seeking information about unpublished or incomplete studies known to be involved in previous studies. </p> </li> </ol> </p> </section> </section> <section id="CD010344-sec-0033"> <h3 class="title" id="CD010344-sec-0033">Data collection and analysis</h3> <section id="CD010344-sec-0034"> <h4 class="title">Selection of studies</h4> <p>The search methods described were used to obtain titles and abstracts of studies that may be relevant to the review. The titles and abstracts were screened independently by three authors who discarded studies that were not applicable. Studies and reviews that might have included relevant data or information were retained for consideration. Three authors independently assessed the retrieved abstracts and full texts, if necessary, to determine which studies satisfied the inclusion criteria. </p> </section> <section id="CD010344-sec-0035"> <h4 class="title">Data extraction and management</h4> <p>Three authors were involved in the data extraction process. Data extraction was carried out independently by at least two authors using a standard data extraction form. Studies reported in non‐English language journals were translated before assessment. Where more than one publication of a study existed, reports were grouped together and the report with the most complete data was used in the analyses. Where relevant outcomes were only published in less complete versions, these data were used. Any discrepancy between published reports was highlighted. If information about results or study methodology was missing from the original publication, authors were contacted for additional information. </p> </section> <section id="CD010344-sec-0036"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>The following items were independently assessed by at least two authors using the risk of bias assessment tool (<a href="./references#CD010344-bbs2-0042" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>) (see <a href="./appendices#CD010344-sec-0082">Appendix 2</a>). </p> <p> <ul id="CD010344-list-0006"> <li> <p>Was there adequate sequence generation (selection bias)?</p> </li> <li> <p>Was allocation adequately concealed (selection bias)?</p> </li> <li> <p>Was knowledge of the allocated interventions adequately prevented during the study?</p> <ul id="CD010344-list-0007"> <li> <p>Participants and personnel (performance bias)</p> </li> <li> <p>Outcome assessors (detection bias)</p> </li> </ul> </li> <li> <p>Were incomplete outcome data adequately addressed (attrition bias)?</p> </li> <li> <p>Are reports of the study free of suggestion of selective outcome reporting (reporting bias)? </p> </li> <li> <p>Was the study apparently free of other problems that could put it at a risk of bias?</p> </li> </ul> </p> </section> <section id="CD010344-sec-0037"> <h4 class="title">Measures of treatment effect</h4> <p>For dichotomous outcomes (death, arrhythmia, ECG changes), results were to be expressed as risk ratio (RR) with 95% confidence intervals (CI). Where continuous scales of measurement were used to assess the effects of treatment (serum potassium), the mean difference (MD) was used, or the standardised mean difference (SMD) if different scales had been used. Change scores were to be used if results were not available as another type and these were combined with other results using the MD. If studies did not report the within study variance for continuous outcomes we had planned to impute the standard deviation using the average standard deviation from other studies. Because of the small number of studies with complete statistical information and comparing similar interventions imputation was not possible. </p> <p>All studies of a particular pharmacological therapy were to be analysed together regardless of route of administration or dose. We reported doses and routes of administration separately because there were too few studies to perform a meta‐analysis. We intended to perform subgroup analyses to identify any effect of route or dose, but there were not enough studies with sufficient statistical data looking at the same intervention. </p> </section> <section id="CD010344-sec-0038"> <h4 class="title">Unit of analysis issues</h4> <p>Cross‐over studies were available for inclusion in this review and we had planned to include the paired results in the analysis using the generic inverse‐variance method or if studies did not report the necessary data for paired analysis to impute the missing standard deviations. If that was not possible we planned to include the results in the analysis as unpaired data and a sensitivity analysis was to be performed to assess the effect of including data in this manner. Because we were unable to perform a meta‐analysis, and because paired data were not available we included the first phase of cross‐over studies as unpaired data, but sensitivity analysis was not performed. </p> <p>For studies with multiple interventions comparing a single pharmacological therapy given by a different route or dose to a control group, we had planned to combine all relevant groups into a single group. Because there were insufficient data to perform a meta‐analysis we included the groups separately. </p> </section> <section id="CD010344-sec-0039"> <h4 class="title">Dealing with missing data</h4> <p>Any further information required from the original author was requested by written correspondence, and any relevant information obtained in this manner was to be included in the review. The number of screened and randomised patients, as well as intention‐to‐treat, as‐treated and per‐protocol populations were carefully evaluated. Attrition rates, including drop‐outs, losses to follow‐up and withdrawals, were investigated. We considered the impact of missing data on study results and critically appraised imputation methods employed by the authors. </p> </section> <section id="CD010344-sec-0040"> <h4 class="title">Assessment of heterogeneity</h4> <p>We planned to identify heterogeneity using a Chi² test with N‐1 degrees of freedom and an alpha of 0.10 and if present, quantify the degree of heterogeneity using the I² index with values of 25%, 50% and 75% corresponding to low, medium and high levels of heterogeneity (<a href="./references#CD010344-bbs2-0041" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [MEDLINE: 12958120] ">Higgins 2003</a>). Because we were unable to combine study data we did not assess for heterogeneity. </p> </section> <section id="CD010344-sec-0041"> <h4 class="title">Assessment of reporting biases</h4> <p>Funnel plots were to be prepared to assess for the potential existence of small study bias (<a href="./references#CD010344-bbs2-0042" title="HigginsJP , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Because we were not able to combine study data we could not perform funnel plots. </p> </section> <section id="CD010344-sec-0042"> <h4 class="title">Data synthesis</h4> <p>Data were to be pooled using the random‐effects model. The fixed‐effect model was also to be used to ensure robustness of the chosen model and susceptibility to outliers. No data synthesis was performed. </p> </section> <section id="CD010344-sec-0043"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Subgroup analysis was to be used to explore possible sources of heterogeneity (e.g. participants, intervention, study quality). Heterogeneity among studies was anticipated to be related to patient age, comorbidities, kidney function, and co‐administration of medications. Heterogeneity among participants was anticipated in relation to patient age, kidney function, aetiology of hyperkalaemia, duration of hyperkalaemia, comorbidities, and co‐administration of medications. Heterogeneity in treatments was thought to potentially apply to prior therapeutic agents used, time to administration and the agent dose, route of administration and duration of therapy. Adverse effects were to be tabulated and assessed using descriptive techniques, because they were thought likely to vary among the different agents. Where possible, the risk difference was to be calculated with a 95% CI for each adverse effect, compared to no treatment or to another agent. </p> <p>Subgroup analysis was not possible due to the limited number of included studies.</p> </section> <section id="CD010344-sec-0044"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses to explore the influence of the following factors on effect size. </p> <p> <ul id="CD010344-list-0008"> <li> <p>Repeating the analysis excluding unpublished studies</p> </li> <li> <p>Repeating the analysis taking account of risk of bias</p> </li> <li> <p>Repeating the analysis excluding any very long or large studies to establish how much they influence the results </p> </li> <li> <p>Repeating the analysis excluding studies using the following filters: diagnostic criteria, language of publication, source of funding (industry versus other), and country </p> </li> </ul> </p> <p>No synthesis was performed so sensitivity analyses were not possible.</p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD010344-sec-0045" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD010344-sec-0045"></div> <section id="CD010344-sec-0046"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD010344-sec-0087" title="">Characteristics of included studies</a>; <a href="./references#CD010344-sec-0088" title="">Characteristics of excluded studies</a>; Characteristics of studies awaiting classification; and Characteristics of ongoing studies. </p> <section id="CD010344-sec-0047"> <h4 class="title">Results of the search</h4> <p>The search of the Specialised Register (up to 18 August 2015) identified 166 citations of which 108 were excluded (non‐RCTs, wrong patient population, or studies that evaluated interventions not relevant to this review). Three additional citations were identified through the reference lists of studies and review articles. The full text of potentially relevant studies was reviewed; of these, 16 did not meet our inclusion criteria (<a href="#CD010344-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD010344-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram" data-id="CD010344-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> </div> <p>We included seven studies (eight reports) (<a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a>; <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a>; <a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a>; <a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>; <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>). </p> <p>Prior to publication eight potential studies (31 reports) (<a href="./references#CD010344-bbs2-0024" title="BakrisGL , PittB , WeirMR , FreemanMW , MayoMR , GarzaD , et al. Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: The AMETHYST‐DN Randomized Clinical Trial. JAMA2015;314(2):151‐61. [MEDLINE: 26172895] PittB , BushinskyD , GarzaD , StasivY , Du MondC , BermanL , et al. 1‐year safety and efficacy of patiromer for hyperkalemia in heart failure patients with chronic kidney disease on renin‐angiotensin‐aldosterone system inhibitors [abstract]. Journal of the American College of Cardiology2015;65(10 Suppl 1):A855. [EMBASE: 71833912] ">AMETHYST‐DN Study 2015</a>; <a href="./references#CD010344-bbs2-0025" title="AshSR , SinghB , LavinPT , StavrosF , RasmussenHS . A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS‐9, is safe and efficient. Kidney International2015;88(2):404‐11. [MEDLINE: 25651363] SinghB , AshSA , LavinPT , YangA , RasmussenHS . ZS‐9, a novel selective cation trap, leads to a rapid and predictable rate of decline in serum potassium in patients with chronic kidney disease and hyperkalemia [abstract]. Journal of the American College of Cardiology2014;63(12 Suppl 1):A369. [EMBASE: 71406393] SinghB , AshSR , LavinPT , YangA , RasmussenHS . Acid‐base balance in a phase 2 trial of ZS‐9 for hyperkalaemia in patients with chronic kidney disease [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii155. [EMBASE: 71491879] ">Ash 2015</a>; <a href="./references#CD010344-bbs2-0026" title="ChothiaMY , HalperinML , RensburgMA , HassanMS , DavidsMR . Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial. Nephron. Physiology2014;126(1):1‐8. [MEDLINE: 24576893] ">Chothia 2014</a>; <a href="./references#CD010344-bbs2-0027" title="El‐ShahawyMA , RasmussenHS , LavinPT , YangA , QunibiW . Treatment of hyperkalemia with ZS‐9, a selective nonabsorbed cation exchange resin, does not lead to hypomagnesemia: results from two multicenter, randomized, double blind, placebo‐controlled phase 3 trials [abstract]. Journal of the American College of Cardiology2015;65(10 Suppl 1):A842. [EMBASE: 71833899] KosiborodM , RasmussenHS , LavinP , QunibiWY , SpinowitzB , PackhamD , et al. Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial. JAMA2014;312(21):2223‐33. [MEDLINE: 25402495] LermaE , KosiborodM , RasmussenHS , LavinPT , YangA , QunibiW . Sodium zirconium cyclosilicate (ZS‐9) for hyperkalemia in stage 4/5 CKD subgroup of the phase 3 HARMONIZE study [abstract]. American Journal of Kidney Diseases2015;65(4):A54. [EMBASE: 71875137] PeacockW , RafiqueZ , RasmussenH , LavinP , YangA , LevyP , et al. Sodium zirconium cyclosilicate (ZS‐9) for severe hyperkalemia: A post‐HOC analysis of the phase 3 HARMONIZE trial [abstract]. Academic Emergency Medicine2015;22(5 Suppl 1):S69. [EMBASE: 71878784] QunibiW , KosiborodM , RasmussenHS , LavinPT , YangA , LermaE . Safety of sodium zirconium cyclosilicate (ZS‐9) in hyperkalemia: Analysis of GI effects in the phase 3 HARMONIZE study [abstract]. American Journal of Kidney Diseases2015;65(4):A69. [EMBASE: 71875193] QunibiW , KosiborodM , RasmussenHS , LavinPT , YangA , LermaE . Sodium zirconium cyclosilicate (ZS‐9) in hyperkalemic patients with CKD on RAAS inhibitors: Subgroup analysis of phase 3 HARMONIZE study [abstract]. American Journal of Kidney Diseases2015;65(4):A70. [EMBASE: 71875194] ZannadF , RasmussenHS , LavinPT , SinghB , YangA , AnkerSD . Sodium zirconium cyclosilicate for treatment of hyperkalaemia: Analysis of patients on renin‐angiotensin‐aldosterone inhibitors (RAASi) from the phase 3 HARMONIZE study [abstract]. Journal of Hypertension2015;33:e450‐1. [EMBASE: 71936068] ZannadF , RasmussenHS , LavinPT , YangA , SinghB , AnkerSD . Effect of sodium zirconium cyclosilicate (ZS‐9) on aldosterone from the phase 3 randomized, double‐blind, placebo‐controlled HARMONIZE study [abstract]. European Journal of Heart Failure2015;17:342. [EMBASE: 71903670] ">HARMONIZE Study 2014</a>; <a href="./references#CD010344-bbs2-0028" title="NasirK , AhmadA . Treatment of hyperkalemia in patients with chronic kidney disease: a comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate. Journal of Ayub Medical College, Abbottabad: JAMC2014;26(4):455‐8. [MEDLINE: 25672163] ">Nasir 2014</a>; <a href="./references#CD010344-bbs2-0029" title="PittB , WeirMR , MayoMR , GarzaD , Christ‐SchmidtH , WittesJ , et al. Patiromer lowers serum potassium and prevents recurrent hyperkalemia in patients with heart failure and CKD when treated with RAAS inhibitors: Results from OPAL‐HK [abstract]. European Journal of Heart Failure2015;17:90. [EMBASE: 71902792] WeirM , BushinskyD , MayoM , GarzaD , StasivY , ArthurS , et al. Patiromer reduced recurrent hyperkalemia in advanced CKD patients on RAASI [abstract]. American Journal of Kidney Diseases2015;65(4):A90. [EMBASE: 71875267] WeirMR , BakrisGL , BushinskyDA , MayoMR , GarzaD , StasivY , et al. Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors. New England Journal of Medicine2015;372(3):211‐21. [MEDLINE: 25415805] ">OPAL‐HK Study 2015</a>; <a href="./references#CD010344-bbs2-0030" title="El‐ShahawyM , RasmussenHS , LavinPT , YangA , PackhamDK . Acute‐phase efficacy of ZS‐9 in patients with baseline serum potassium levels above 5.5 MEQ/l: Analysis from a phase 3, multicenter, randomized, double blind, placebo‐controlled trial [abstract]. Journal of the American College of Cardiology2015;65(10 Suppl 1):A878. [EMBASE: 71833935] El‐ShahawyMA , RasmussenHS , LavinPT , YangA , PackhamDK . Acute‐phase efficacy in a phase 3 multicenter, randomised, double‐blind, placebo‐controlled trial of ZS‐9 for hyperkalaemia [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii178. [EMBASE: 71491947] El‐ShahawyMA , SinghB , RasmussenHS , LavinPT , YangA , QunibiW . Maintenance of normal serum K+ with ZS‐9 once daily in patients with CHF: Subgroup analysis of a phase 3 multicenter, randomised, double‐blind placebo‐controlled trial of patients with hyperkalaemia [abstract]. European Heart Journal2014;35(Suppl 1):722. [EMBASE: 71649437] PackhamDK , RasmussenHS , LavinPT , El‐ShahawyMA , RogerSD , BlockG , et al. Sodium zirconium cyclosilicate in hyperkalemia. New England Journal of Medicine2015;372(3):222‐31. [MEDLINE: 25415807] QunibiW , RasmussenHS , LavinPT , YangA , SinghB . ZS‐9 maintains normokalemia in hyperkalemic patients despite continuing RAAS inhibitors: a subgroup analysis from a phase 3 multicenter, randomized, double blind, placebo‐controlled trial [abstract]. Journal of the American College of Cardiology2015;65(10 Suppl 1):A792. [EMBASE: 71833849] RasmussenHS , BlockGA , LavinPT , El‐ShahawyMA , RogerSD , PackhamDK , et al. Once‐daily ZS‐9, a novel selective potassium trap, maintained normokalemia in patients with diabetes after acute therapy for hyperkalemia [abstract]. Diabetes2014;63:A142. [EMBASE: 71558950] RasmussenHS , BlockGA , LavinPT , El‐ShahawyMA , RogerSD , PackhamDK , et al. ZS‐9, a novel selective potassium trap, rapidly reduced serum potassium in patients with diabetes treated for hyperkalemia [abstract]. Diabetes2014;63:A296. [EMBASE: 71559522] RogerSD , RasmussenHS , LavinPT , YangA , El‐ShahawyMA . Efficacy of ZS‐9 in patients receiving RAAS therapy: a subgroup analysis of a phase 3 multicenter, randomised, double‐blind, placebo‐controlled trial [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii180. [EMBASE: 71491951] RogerSD , RasmussenHS , LavinPT , YangA , QunibiWY . Extended efficacy of ZS‐9 once‐daily in a phase 3 multicenter, randomised, double‐blind, placebo‐controlled trial of patients with hyperkalaemia [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii182. [EMBASE: 71491958] SinghB , RasmussenHS , LavinPT , YangA , PackhamDK . Phase 3, multicenter, randomized, double‐blind, placebo‐controlled trial of once‐daily ZS‐9 for treatment of hyperkalemia: achievement and maintenance of K+ in subgroup analysis of patients with heart failure not on RAAS inhibitors [abstract]. Circulation2014;130(Suppl 1):A17489. [EMBASE: 71712359] SinghB , RasmussenHS , LavinPT , YangA , RogerSD . Phase 3, multicenter, randomised, double‐blind, placebo‐controlled trial of ZS‐9: subgroup analysis stratified by baseline serum potassium levels [abstract]. Nephrology Dialysis Transplantation2014;29(Suppl 3):iii178‐iii. [EMBASE: 71491948] YangA , SinghB , LavinPT , ChangA , RasmussenHS . Placebo effect in clinical studies in hyperkalemia: A double‐blind, randomized, placebo‐controlled phase 3 study of sodium zirconium cyclosilicate (ZS‐9) [abstract]. American Journal of Kidney Diseases2015;65(4):A91. [EMBASE: 71875272] ">Packham 2015</a>; <a href="./references#CD010344-bbs2-0031" title="Ramos‐PenafielCO , Tovilla‐RuizCK , Galvan‐FloresF , Castaneda‐RodriguezR , EspinozaMA , Duran‐GuzmanR , et al. Efficacy of hyperK‐cocktail versus regular insulin in the management of hyperkalemia [Eficacia de hiperK‐cocktail vs insulina regular en el tratamiento de la hipercalemia]. Medicina Interna de Mexico2015;31(1):50‐6. [EMBASE: 2015244383] ">Ramos‐Penafiel 2015</a>) were identified and this will be assessed in a future update of this review. One additional study is ongoing (<a href="./references#CD010344-bbs2-0032" title="RasmussenH . Multicenter, multi‐dose, open‐label maintenance of long‐term safety and efficacy of sodium zirconium cyclosilicate (ZS) in hyperkalemia, including a randomized, double‐blind, placebo‐controlled withdrawal. clinicaltrials gov/ct2/show/NCT02163499 (accessed 18 August 2015). ">NCT02163499</a>). </p> </section> <section id="CD010344-sec-0048"> <h4 class="title">Included studies</h4> <p>Refer to <a href="./references#CD010344-sec-0087" title="">Characteristics of included studies</a> </p> <p>Seven studies (241 participants) were included in this review; five were randomised, parallel group studies (<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a>; <a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>; <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) and two were cross‐over studies (<a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a>; <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a>). The included studies evaluated many different interventions, but only two studies included a placebo group (<a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>). None of the studies included in this review evaluated the efficacy of pharmacological interventions at preventing clinical outcomes such as mortality and cardiac arrhythmias. All included studies focused on the effect of pharmacological interventions on serum potassium levels. </p> <p>None of the included studies evaluated IV calcium or potassium binding resins in the treatment of hyperkalaemia. </p> <p> <ul id="CD010344-list-0009"> <li> <p><a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> compared different doses of nebulised salbutamol with placebo. </p> </li> <li> <p><a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> studied salbutamol, insulin‐dextrose and a combination of both agents. Results were reported graphically and numerically but the study did not provide sufficient statistical information for meta‐analysis. After being contacted for further information, the study authors kindly provided the serum potassium results (a continuous variable) as final values rather than as the change scores that were reported in the original article. </p> </li> <li> <p><a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a> compared salbutamol given via IV or nebuliser and reported their results graphically and numerically. Some of the graphically reported data included statistical measures of variance. The authors were contacted for comprehensive numerical data but no response was received. </p> </li> <li> <p><a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> compared IV and nebulised salbutamol. The authors excluded all patients who did not respond to therapy (decrease in potassium of at least 0.5 mEq/L). The authors were contacted for the full study results, including data from those patients who were excluded, but no response was received. </p> </li> <li> <p><a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a> compared IV aminophylline and IV insulin‐dextrose and reported primarily on the change in plasma potassium. The study reported sufficient information for the results to be included in a meta‐analysis; however this was not performed because no other study looked at aminophylline. </p> </li> <li> <p><a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> compared salbutamol given by metered‐dose inhaler (MDI) with placebo. The results were not reported with sufficient statistical information for inclusion in a meta‐analysis. This limited our ability to combine the results with <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a>. The authors were contacted for additional information but no response was received. </p> </li> <li> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> compared seven different treatment regimens. Some of the results were missing standard deviations. The authors were contacted for comprehensive results but they were unable to provide us with the data requested. </p> </li> </ul> </p> <p>The studies included in this review evaluated many different pharmacological interventions and serum potassium was monitored at several time points. We were unable to meta‐analyse the results due to heterogeneity among interventions and timing of outcomes. Furthermore, the study results were typically not reported using standard statistical information necessary for meta‐analysis. For example, standard deviations were not reported for all results in three studies (<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>; <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>). We were unable to impute standard deviations for the missing data because there were too few studies. All authors were contacted for additional information on study methodology and results. Additional data was obtained for <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> and <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> only. For most studies the results were extracted as serum potassium change scores as that provided the most complete data. </p> </section> <section id="CD010344-sec-0049"> <h4 class="title">Excluded studies</h4> <p>See: <a href="./references#CD010344-sec-0088" title="">Characteristics of excluded studies</a> </p> <p>Six studies were excluded for studying normokalaemic patients (<a href="./references#CD010344-bbs2-0008" title="AllonM , TakeshianA , ShanklinN . Effect of insulin‐plus‐glucose infusion with or without epinephrine on fasting hyperkalemia. Kidney International1993;43(1):212‐7. [MEDLINE: 8433561] ">Allon 1993</a>; <a href="./references#CD010344-bbs2-0009" title="AllonM , ShanklinN . Effect of albuterol treatment on subsequent dialytic potassium removal. American Journal of Kidney Diseases1995;26(4):607‐13. [MEDLINE: 7573015] ">Allon 1995</a>; <a href="./references#CD010344-bbs2-0010" title="AllonM , ShanklinN . Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. American Journal of Kidney Diseases1996;28(4):508‐14. [MEDLINE: 8840939] ">Allon 1996</a>; <a href="./references#CD010344-bbs2-0013" title="DeWolfA , FrenetteL , KangY , TangC . Insulin decreases the serum potassium concentration during the anhepatic stage of liver transplantation. Anesthesiology1993;78(4):677‐82. [MEDLINE: 8466068] ">De Wolf 1993</a>; <a href="./references#CD010344-bbs2-0014" title="Gruy‐KapralC , EmmettM , Santa AnaCA , PorterJL , FordtranJS , FineKD . Effect of single dose resin‐cathartic therapy on serum potassium concentration in patients with end‐stage renal disease. Journal of the American Society of Nephrology1998;9(10):1924‐30. [MEDLINE: 9773794] ">Gruy‐Kapral 1998</a>; <a href="./references#CD010344-bbs2-0023" title="WangP , ClausenT . Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol. Lancet1976;307(7953):221‐3. [MEDLINE: 55532] ">Wang 1976</a>) and seven because they were not randomised (<a href="./references#CD010344-bbs2-0011" title="BlumgergA , WeidmannP , ShawS , GnadingerM . Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. American Journal of Medicine1988;85(4):507‐12. [MEDLINE: 3052050] ">Blumberg 1998</a>; <a href="./references#CD010344-bbs2-0015" title="KimHJ , ChoGS , YangSC . The combined regimen of bicarbonate and beta2‐agonist (salbutamol) in acute therapy of hyperkalemia in hemodialysis patients [abstract]. Nephrology Dialysis Transplantation1996;11(6):A161. [CENTRAL: CN‐00261267] ">Kim 1996</a>;<a href="./references#CD010344-bbs2-0017" title="LensXM , MontoliuJ , CasesA , CampistolJM . Absence of synergistic effect between salbutamol (S) and aminophylline (A) for the treatment of hyperkalemia in renal failure [abstract]. 24th Annual Congress. EDTA‐ERA; 1987 Oct 25‐29; West Berlin, Germany. 1987:75. [CENTRAL: CN‐00601990] ">Lens 1987</a>; <a href="./references#CD010344-bbs2-0018" title="LensXM , MontoliuJ , CasesA , CampistolJM , RevertL . Treatment of hyperkalaemia in renal failure: salbutamol v. insulin. Nephrology Dialysis Transplantation1989;4(3):228‐32. [MEDLINE: 2498781] LensXM , MontoliuJ , CasesA , RevertL . Treatment of hyperkalemia in renal failure: Salbutamol versus glucose and insulin [abstract]. Kidney International1987;32(4):623. [CENTRAL: CN‐00583537] ">Lens 1989</a>; <a href="./references#CD010344-bbs2-0020" title="MocanMZ , MocanG , MocanH , GorinB . Inhaler salbutamol for acute hyperkalemia in renal failure. Israel Journal of Medical Science1993;29(1):39‐41. [MEDLINE: 8454446] ">Mocan 1993</a>; <a href="./references#CD010344-bbs2-0021" title="MushtaqMA , MasoodM . Treatment of hyperkalemia with salbutamol and insulin. Pakistan Journal of Medical Sciences2006;22(2):176‐9. [EMBASE: 2006258815] ">Mustaq 2006</a>; <a href="./references#CD010344-bbs2-0022" title="PancuD , LaFlammeM , EvansE , ReedJ . Levalbuterol is as effective as racemic albuterol in lowering serum potassium. Journal of Emergency Medicine2003;25(1):13‐6. [MEDLINE: 12865102] ">Pancu 2003</a>). Two studies were excluded because they studied chronic rather than acute management of hyperkalaemia (<a href="./references#CD010344-bbs2-0012" title="BuysseJM , HuangIZ , PittB . PEARL‐HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016. Future Cardiology2012;8(1):17‐28. [MEDLINE: 22185443] ">Buysse 2012</a>; <a href="./references#CD010344-bbs2-0016" title="KimDM , ChungJH , YoonSH , KimHL . Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end‐stage renal disease undergoing haemodialysis. Nephrology Dialysis Transplantation2007;22(11):3273‐6. [MEDLINE: 17616536] ">Kim 2007a</a>) and one was excluded because it was performed in children (<a href="./references#CD010344-bbs2-0019" title="McClureRJ , PrasadVK , BrocklebankJT . Treatment of hyperkalaemia using intravenous and nebulised salbutamol. Archives of Disease in Childhood1994;70(2):126‐8. [MEDLINE: 8129434] ">McClure 1994</a>). </p> </section> </section> <section id="CD010344-sec-0050"> <h3 class="title">Risk of bias in included studies</h3> <p>See: <a href="#CD010344-fig-0002">Figure 2</a> and <a href="#CD010344-fig-0003">Figure 3</a> </p> <div class="figure" id="CD010344-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD010344-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> </div> <div class="figure" id="CD010344-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010344-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> </div> <p>The majority of included studies were assessed as having an unclear risk of bias due to poor methodological reporting. Most studies did not describe allocation methodology or indicate if the study was blinded. Overall, studies mostly reported all specified outcome data; only <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> demonstrated selective reporting. <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> was assessed as having a low risk of bias. </p> <section id="CD010344-sec-0051"> <h4 class="title">Allocation</h4> <p>Allocation methodology was poorly reported in most studies. <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> and <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> did not report randomisation or allocation concealment methodology but the studies were confirmed to be randomised after discussion with the study authors. <a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>, <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> and <a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a> reported that they randomised the patients into two groups but did not provide any information on how the randomised sequence was generated or how allocation concealment was maintained. <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> applied a restricted randomisation method with permuted blocks. <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> reported that the randomisation code was held by the study biostatistician. </p> </section> <section id="CD010344-sec-0052"> <h4 class="title">Blinding</h4> <p>Blinding methodology was poorly described in most studies. Four studies (<a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a>; <a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a>; <a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a>) did not report blinding. <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a>, <a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a> and <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> compared nebulised and IV medications and did not report use of a double‐dummy technique, so it was unlikely that the studies were blinded. <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> was reported to be double‐blind with nurses and patients blinded but not physicians. <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> was double‐blind with both investigators and patients blinded and placebo MDI were used to maintain blinding. <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> was reported to be single‐blind but no additional information was provided. For those studies that did implement blinding, there was no assessment of the maintenance of blinding at the end of the treatment period. Despite the lack of blinding, the effects are likely to be minor due to the objective nature of the outcome. </p> </section> <section id="CD010344-sec-0053"> <h4 class="title">Incomplete outcome data</h4> <p>Four studies (<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a>; <a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) did not report any patients withdrawing from the study. <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> and <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> both had two patients with missing data due to early termination and neither study described how the missing data was handled. In <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>, a parallel group randomised study, 10% of patients were urgently dialysed for treatment of hyperkalaemia and thus withdrew from the study. The authors provided information on when and from which groups these patients left the studies. No patient left the study until after 120 minutes of data had been collected. Two patients from the IV salbutamol group had been started on dialysis prior to the 240 minute data collection. Five more patients were started on dialysis prior to the final 480 minute data collection. One patient withdrew from each from the following groups: insulin‐dextrose, IV salbutamol, bicarbonate‐IV salbutamol, and insulin‐dextrose‐IV salbutamol groups. The authors did not describe how they handled the missing data. </p> </section> <section id="CD010344-sec-0054"> <h4 class="title">Selective reporting</h4> <p>Study protocols were not available for any of the included studies. None of the study reports clearly defined their primary and secondary outcomes, thereby making it difficult to assess for selective reporting in most studies. </p> <p><a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> excluded patients from their final analysis who did not have a maximal decrease in potassium of at least 0.5 mmol/L. This resulted in 6/18 patients in the IV salbutamol group and 4/16 patients in the nebulised salbutamol group being excluded. These exclusions result in a biased estimate of treatment effect and are a serious flaw in the study design. The authors of the study were contacted but no response was received. Three studies (<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>; <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) did not report the standard deviations for several of the potassium outcomes making them impossible to meta‐analyse. </p> </section> <section id="CD010344-sec-0055"> <h4 class="title">Other potential sources of bias</h4> <p>No other sources of bias were identified.</p> </section> </section> <section id="CD010344-sec-0056"> <h3 class="title" id="CD010344-sec-0056">Effects of interventions</h3> <section id="CD010344-sec-0057"> <h4 class="title">Salbutamol versus placebo</h4> <p>Salbutamol was compared to placebo in two studies (<a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a>; <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) but could not be meta‐analysed because standard deviations for the placebo group were not available for <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>. </p> <p><a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> reported significantly greater reduction in serum potassium with 10 mg and 20 mg nebulised salbutamol compared with placebo. The peak effect of 10 mg nebulised salbutamol was seen at 120 minutes (<a href="./references#CD010344-fig-0004" title="">Analysis 1.1</a>.4: MD ‐1.29 mmol/L, 95% CI ‐1.64 to ‐0.94) and at 60 and 90 minutes for 20 mg nebulised salbutamol (<a href="./references#CD010344-fig-0005" title="">Analysis 2.1</a>.2; <a href="./references#CD010344-fig-0005" title="">Analysis 2.1</a>.3) (60 minutes: MD ‐‐1.16 mmol/L, 95% CI ‐1.53 to ‐0.79; 90 minutes: MD ‐1.18 mmol/L, 95% CI ‐1.54 to ‐0.82). <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> reported a significant increase in serum potassium with 1.2 mg salbutamol via MDI at 1 minute (MD 0.12 mmol/L, P &lt; 0.05) but subsequent significant decreases in serum potassium beginning at 10 minutes (MD ‐0.20 mmol/L, P &lt; 0.05) and a maximal decrease at 60 minutes (MD ‐0.34 mmol/L, P &lt; 0.0001). </p> <p>Both <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> and <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> found that inhaled salbutamol increased heart rate in exposed patients. In <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> only minimal side effects were reported. <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> mentioned they would record known side effects of salbutamol but no side effects were mentioned (see <a href="#CD010344-tbl-0001">Table 1</a>). </p> <div class="table" id="CD010344-tbl-0001"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Side effects and adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment group(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One patient receiving salbutamol nebules experienced mild anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nine patients receiving insulin‐dextrose experienced hypoglycaemia</p> <p>Two patients receiving insulin‐dextrose combined with salbutamol nebules experienced hypoglycaemia </p> <p>Patients receiving insulin‐dextrose combined with salbutamol nebules had a significant increase in heart rate </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 patients receiving salbutamol IV and two patients receiving salbutamol nebules experienced minor adverse effects (headache, dizziness, palpations) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three patients receiving salbutamol IV experienced adverse effects (transient tachycardia, palpation, mild chest tightness) </p> <p>One patient receiving salbutamol nebules experienced mild, transient dizziness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One patient receiving insulin‐dextrose experienced hypoglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients receiving salbutamol MDI had an increase in heart rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse effects not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>IV ‐ intravenous; MDI ‐ metered‐dose inhaler</p> </div> </div> </section> <section id="CD010344-sec-0058"> <h4 class="title">Salbutamol versus salbutamol</h4> <p><a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> found a significantly greater reduction in serum potassium with 20 mg nebulised salbutamol compared with 10 mg nebulised salbutamol but only at the 120 minute time point (<a href="./references#CD010344-fig-0006" title="">Analysis 3.1</a>.3: MD ‐0.42 mmol/L, 95% CI ‐0.09 to ‐0.75). One patient reported mild anxiety after the 20 mg dose. </p> <p><a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a> reported no significant difference in serum potassium between 0.5 mg IV salbutamol and 10 mg nebulised salbutamol. Standard deviations were not reported for some of these outcomes and therefore these results could not be meta‐analysed (see <a href="#CD010344-tbl-0002">Table 2</a>). Minor side effects (headache, dizziness, palpations) were more common with 0.5 mg IV salbutamol than 10 mg nebulised salbutamol (15 versus 2) (<a href="#CD010344-tbl-0001">Table 1</a>). </p> <div class="table" id="CD010344-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Serum potassium (mmol/L)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Comparisons<br/> (study ID)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>Time points (mean ± SD* (number of participants))</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1 minute</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3 minutes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>5 minutes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>10 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>60 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>120 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>240 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>480 minutes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (0.5 mg IV)</p> <p>(<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.76 ± 0.26 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.70 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (10 mg nebulised)</p> <p>(<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.69 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.71 ± 0.11 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (MDI)</p> <p>(<a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.55 ± 0.17 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 ± 0.16 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.33 ± 0.17 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.22 ± 0.16 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.17 ± 0.17 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1 ± 0.18 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> <p>(<a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.42 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.44 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.44 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insulin dextrose (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.85 ± 0.47 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.44 ± 0.66 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.90 ± 0.45 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.61 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.41 (9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.80 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.03 ± 0.41 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.90 ± 0.56 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.65 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.48 (7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sodium bicarbonate (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.47 ± 0.31 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.57 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.6 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.48 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insulin‐dextrose IV plus sodium bicarbonate (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.85 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.17 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.19 ± 0.5 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.99 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.71 (10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insulin‐dextrose IV plus salbutamol (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.09 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.39 ± 0.66 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.18 ± 0.69 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.85 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.62 (10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol IV plus sodium bicarbonate (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.71 ± 0.43 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.81 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.72 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.57 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.36 (10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol IV plus sodium bicarbonate (IV)</p> <p>plus Insulin‐dextrose IV (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.2 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.55 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.69 ± 0.54 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.29 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.05 (9)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>* if provided; ‐‐ not reported</p> <p>Iv ‐ intravenous; MDI ‐ metered‐dose inhaler</p> </div> </div> <p><a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> reported a significant decrease in serum potassium with 0.5 mg IV salbutamol compared to 10 mg nebulised salbutamol at 10 (MD ‐0.50 mmol/L, 95% CI ‐0.66 to ‐0.34), 20 (MD ‐0.50 mmol/L, 95% CI ‐0.66 to ‐0.34), 30 (MD ‐0.40 mmol/L, ‐0.56 to ‐0.24) and 60 minutes (MD ‐0.20 mmol/L, 95% CI ‐0.36 to ‐0.04) but not at 120 and 180 minutes (<a href="./references#CD010344-fig-0007" title="">Analysis 4.1</a>). Side effects (transient tachycardia, palpitation, mild chest tightness) occurred in three patients in the IV group while only one patient in the nebulised group experienced mild, transient dizziness. </p> </section> <section id="CD010344-sec-0059"> <h4 class="title">Salbutamol versus insulin‐dextrose</h4> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported no significant differences in serum potassium reduction between IV salbutamol and IV insulin‐dextrose at 60 and 120 minutes (<a href="./references#CD010344-fig-0008" title="">Analysis 5.1</a>). Standard deviations were not reported for some of the time points and therefore these results could not be meta‐analysed (see <a href="#CD010344-tbl-0002">Table 2</a>). Adverse effects were not reported. </p> <p><a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> reported IV insulin‐dextrose significantly reduced serum potassium compared to 20 mg nebulised salbutamol at 15 minutes (<a href="./references#CD010344-fig-0009" title="">Analysis 6.1</a>.1: MD 0.41 mmol/L, 95% CI 0.14 to 0.68) but not at 30, 45 or 60 minutes. Insulin‐dextrose therapy caused significant hypoglycaemia (mean plasma glucose concentration 2.8 ± 0.3 mmol/L) at 60 minutes, whereas salbutamol resulted in a progressive rise in serum glucose (6.8 ± 0.5 mmol/L). </p> </section> <section id="CD010344-sec-0060"> <h4 class="title">Salbutamol versus sodium bicarbonate</h4> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> did not report standard deviations and therefore we were unable to perform meta‐analyses. Adverse effects were not reported. </p> </section> <section id="CD010344-sec-0061"> <h4 class="title">Salbutamol versus combination therapies</h4> <p><a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> reported 20 mg nebulised salbutamol plus IV insulin dextrose significantly reduced serum potassium compared to 20 mg nebulised salbutamol alone at all time points. The difference was apparent at 15 minutes (<a href="./references#CD010344-fig-0010" title="">Analysis 7.1</a>.1: MD 0.53 mmol/L, 95% CI 0.21 to 0.85) and persisted at a similar magnitude until the study finished at 60 minutes (<a href="./references#CD010344-fig-0010" title="">Analysis 7.1</a>.4: MD 0.55 mmol/L, 95% CI 0.04 to 1.06). Two patients in the combination group had hypoglycaemia and the combination group had a significant increase in heart rate. These adverse effects did not occur in the salbutamol group. </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported no significant difference in serum potassium reduction between IV salbutamol alone compared to IV salbutamol plus IV insulin‐dextrose at 60 and 120 minutes (<a href="./references#CD010344-fig-0011" title="">Analysis 8.1</a>). Standard deviations were not reported for the remaining time points. </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> did not report standard deviations for IV salbutamol alone versus IV salbutamol plus IV bicarbonate and therefore we were unable to perform meta‐analyses. </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported no significant difference in serum potassium reduction between IV salbutamol versus IV insulin‐dextrose plus IV sodium bicarbonate at 120 minutes (<a href="./references#CD010344-fig-0012" title="">Analysis 9.1</a>). Standard deviations were not available for the remaining time points. </p> <p>A combination of salbutamol IV, insulin‐dextrose IV and bicarbonate IV produced a significantly greater reduction in serum potassium than IV salbutamol alone at 120 minutes (<a href="./references#CD010344-fig-0013" title="">Analysis 10.1</a>: MD 0.79 mmol/L, 0.31 to 1.27). Standard deviations were not available for any other time points (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>). </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported a statistically significant difference between initial and repeat plasma glucose concentrations after each combination therapy, but adverse effects were not reported (see <a href="#CD010344-tbl-0001">Table 1</a>). </p> </section> <section id="CD010344-sec-0062"> <h4 class="title">Insulin‐dextrose versus placebo</h4> <p>No studies compared insulin‐dextrose with placebo.</p> </section> <section id="CD010344-sec-0063"> <h4 class="title">Insulin‐dextrose versus sodium bicarbonate</h4> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported IV insulin‐dextrose significantly reduced serum potassium compared to IV sodium bicarbonate IV at 30 minutes (<a href="./references#CD010344-fig-0014" title="">Analysis 11.1</a>: ‐0.38 mmol/L, 95% CI ‐0.73 to ‐0.03). Standard deviations for results beyond 30 minutes were not available. Adverse effects were not reported (see <a href="#CD010344-tbl-0001">Table 1</a>). </p> </section> <section id="CD010344-sec-0064"> <h4 class="title">Insulin‐dextrose versus aminophylline</h4> <p><a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a> reported IV insulin‐dextrose significantly reduced serum potassium compared to IV aminophylline at 60 minutes (<a href="./references#CD010344-fig-0015" title="">Analysis 12.1</a>.1: MD 0.32 mmol/L, 95% CI 0.12 to 0.52), 180 minutes (<a href="./references#CD010344-fig-0015" title="">Analysis 12.1</a>.2: MD ‐0.28 mmol/L, 95 % CI ‐0.52 to ‐0.04) and 360 minutes (<a href="./references#CD010344-fig-0015" title="">Analysis 12.1</a>.3: MD ‐0.32 mmol/L, 95 % CI ‐0.56 to ‐0.08). There was one episode of hypoglycaemia in the insulin‐dextrose group. </p> </section> <section id="CD010344-sec-0065"> <h4 class="title">Insulin‐dextrose versus combination therapies</h4> <p><a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> reported IV insulin‐dextrose IV plus 20 mg nebulised salbutamol significantly reduced serum potassium compared to IV insulin‐dextrose alone at 30 minutes (<a href="./references#CD010344-fig-0016" title="">Analysis 13.1</a>.2: 0.27 mmol/L, 95% CI 0.02 to 0.52), 45 minutes (<a href="./references#CD010344-fig-0016" title="">Analysis 13.1</a>.3: 0.39 mmol/L, 95% CI 0.06 to 0.72), and 60 minutes (<a href="./references#CD010344-fig-0016" title="">Analysis 13.1</a>.4: 0.66 mol/L, 95% CI 0.14 to 1.18), but not at 15 minutes. Hypoglycaemia occurred in 9/12 patients with insulin‐dextrose alone and 2/10 with the combination of insulin‐dextrose and salbutamol (P = 0.01). The combination group had a significant increase in heart rate while the salbutamol alone group did not. </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported no significant differences in serum potassium reduction with IV insulin‐dextrose alone compared to its combination with IV salbutamol IV at 30, 60 or 120 minutes (<a href="./references#CD010344-fig-0017" title="">Analysis 14.1</a>). Standard deviations were not reported for 240 or 480 minutes. </p> <p>No significant difference in serum potassium reduction was reported between IV insulin‐dextrose alone compared to its combination with IV sodium bicarbonate at 120 minutes (<a href="./references#CD010344-fig-0018" title="">Analysis 15.1</a>). Standard deviations were not reported for any other time points (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>). </p> <p>No significant difference in serum potassium levels was reported between IV insulin‐dextrose and IV salbutamol plus IV sodium bicarbonate at 30 minutes (<a href="./references#CD010344-fig-0019" title="">Analysis 16.1</a>). Standard deviations were not reported for any other time points (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>). </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported the combination of IV insulin‐dextrose, IV salbutamol and IV sodium bicarbonate significantly reduced serum potassium compared to IV insulin‐dextrose alone at 120 minutes (<a href="./references#CD010344-fig-0020" title="">Analysis 17.1</a>: MD ‐0.79 mmol/L 95% CI ‐0.35 to ‐1.23). Standard deviations were not reported for any other time points. Adverse effects were not reported. </p> </section> <section id="CD010344-sec-0066"> <h4 class="title">Sodium bicarbonate versus placebo</h4> <p>No studies compared sodium bicarbonate with placebo.</p> </section> <section id="CD010344-sec-0067"> <h4 class="title">Sodium bicarbonate versus combination therapies</h4> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported no significant difference in reduction in serum potassium between IV sodium bicarbonate compared to IV sodium bicarbonate plus IV salbutamol at 30 minutes (<a href="./references#CD010344-fig-0021" title="">Analysis 18.1</a>). Standard deviations were not reported for any other time points </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> reported IV salbutamol IV plus insulin‐dextrose IV significantly reduced serum potassium compared to IV sodium bicarbonate alone at 30 minutes (<a href="./references#CD010344-fig-0022" title="">Analysis 19.1</a>: MD ‐0.62 mmol/L, 95% CI ‐0.21 to ‐1.03). Standard deviations were not reported for any other time points. </p> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> not provide sufficient information to allow us to compare IV sodium bicarbonate alone and combined with IV insulin‐dextrose plus IV salbutamol. Adverse effects were not reported. </p> </section> <section id="CD010344-sec-0068"> <h4 class="title">Combination therapies</h4> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> compared a number of different Combinations of IV insulin‐dextrose, salbutamol and sodium bicarbonate. </p> <p>At 120 minutes there was no significant difference in the reduction of serum potassium between IV insulin‐dextrose plus sodium bicarbonate compared to IV insulin‐dextrose plus IV salbutamol (<a href="./references#CD010344-fig-0023" title="">Analysis 20.1</a>). </p> <p>At 120 minutes IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol significantly decreased serum potassium compared to IV insulin‐dextrose plus IV sodium bicarbonate (<a href="./references#CD010344-fig-0024" title="">Analysis 21.1</a>: MD 0.50 mmol/L, 95% CI 0.04 to 0.96). Standard deviations were not reported for any other time points. </p> <p>There were no significant differences in serum potassium between IV salbutamol and IV sodium bicarbonate compared to IV insulin‐dextrose and IV salbutamol at 30 minutes (<a href="./references#CD010344-fig-0025" title="">Analysis 22.1</a>) or between IV insulin‐dextrose plus IV salbutamol compared to IV insulin dextrose plus IV sodium bicarbonate plus IV salbutamol at 120 minutes (<a href="./references#CD010344-fig-0026" title="">Analysis 23.1</a>). Standard deviations were not reported for any other time points. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD010344-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD010344-sec-0069">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD010344-sec-0104">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD010344-sec-0069"></div> <section id="CD010344-sec-0070"> <h3 class="title" id="CD010344-sec-0070">Summary of main results</h3> <p>Meta‐analysis of the evidence for the acute pharmacological management of hyperkalaemia was not possible because there were a limited number of studies for each intervention and measures of variance were frequently not reported. Consequently, this review presents a narrative summary rather than a meta‐analysis of the available evidence. </p> <p>The studies included in this review provide evidence that several commonly used pharmacological interventions effectively reduce serum potassium and are generally well‐tolerated and safe. There is insufficient evidence to conclude whether these interventions reduce mortality, morbidity or serious adverse events, however we recognize the ethical dilemma of enrolling patients with a potentially life‐threatening condition to a placebo‐controlled study. </p> <p>Salbutamol administered via either nebuliser (<a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a>) or MDI (<a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) decreased serum potassium significantly compared with placebo. IV salbutamol was compared to nebulised salbutamol and the two treatments had comparable effects (<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>; <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a>) suggesting that salbutamol by any route is effective at lowering serum potassium. The results of <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> suggest that IV salbutamol may result in more rapid lowering of serum potassium than other modes of administration. Both <a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a> and <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> reported numerically more minor side effects with salbutamol IV. The maximal decrease in serum potassium ranged from 0.40 mmol/L in <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> and 1.22 mmol/L in <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> with the peak effect occurring approximately 60 to 90 minutes after administration. <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> found that a 20 mg dose of nebulised salbutamol was more effective than 10 mg of nebulised salbutamol without significant differences in side effects. There was no evidence regarding dose response with salbutamol administered via another route. <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> raised safety concerns with salbutamol when they found a small increase in serum potassium one minute after administration of 1.2 mg of salbutamol via MDI. No other study had such early time points and all other studies administered salbutamol over 15 minutes (either as infusion or nebulisation), thus it is unclear whether this early increase in serum potassium is a spurious result, or if a true result, whether or not it is associated with adverse patient outcomes. </p> <p>When compared to other regimens, salbutamol had a similar effect to insulin‐dextrose but was more effective than sodium bicarbonate. <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> found that insulin‐dextrose may have a more rapid onset than salbutamol. The combination of salbutamol and insulin‐dextrose was more effective than either regimen alone in <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> but not in <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>. In <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> the combination of salbutamol and sodium bicarbonate was not more effective than salbutamol alone and the study reports a non‐significant trend to lower potassium in the salbutamol monotherapy group at all time points. </p> <p>Insulin‐dextrose was not studied in any placebo controlled studies, but was found to have a similar effect size to salbutamol in <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> and <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>. The decrease in serum potassium compared with baseline values ranged from 0.55 mmol/L to 1.14 mmol/L. Insulin‐dextrose was more effective than bicarbonate (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) and aminophylline (<a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a>). Insulin‐dextrose in combination with salbutamol may be more effective than salbutamol alone (<a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a>) but this was not found in all studies (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>). </p> <p>IV sodium bicarbonate was not studied in any placebo controlled studies. <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> compared IV sodium bicarbonate with salbutamol and found that bicarbonate was less effective at some time points. <a href="./references#CD010344-bbs2-0010" title="AllonM , ShanklinN . Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. American Journal of Kidney Diseases1996;28(4):508‐14. [MEDLINE: 8840939] ">Allon 1996</a> (not included in this review as it included patients with normal potassium values) found that IV sodium bicarbonate did not provide any additional benefit when combined with insulin‐dextrose or salbutamol. </p> <p>There are no published RCTs evaluating sodium polystyrene or other potassium‐binding resins in hyperkalaemic patients, so we cannot comment on the efficacy of this intervention. <a href="./references#CD010344-bbs2-0014" title="Gruy‐KapralC , EmmettM , Santa AnaCA , PorterJL , FordtranJS , FineKD . Effect of single dose resin‐cathartic therapy on serum potassium concentration in patients with end‐stage renal disease. Journal of the American Society of Nephrology1998;9(10):1924‐30. [MEDLINE: 9773794] ">Gruy‐Kapral 1998</a> (excluded from this review because the patients were not hyperkalaemic) failed to demonstrate any significant effect on serum potassium in a randomised study of sodium polystyrene versus placebo in normokalaemic patients. </p> <p>Evaluation of the evidence for RRT is beyond the scope of this review, but it is worth noting that dialysis is generally considered the definitive treatment for hyperkalaemia. Conventional haemodialysis produces a rapid decrease in serum potassium levels, as do other forms of dialysis such as peritoneal dialysis, continuous venovenous haemofiltration or continuous venovenous haemodialysis. However, dialysis does not work instantaneously and can be challenging to coordinate, so there remains a role for fast‐acting pharmacological treatment options. The magnitude of potassium reduction depends on dialysis duration, dialysate potassium concentration, type of dialyser membrane and patient characteristics such as baseline serum potassium (<a href="./references#CD010344-bbs2-0038" title="EvansKJ , GreenbergA . Hyperkalemia: a review. Journal of Intensive Care Medicine2005;20(5):272‐90. [MEDLINE: 16145218] ">Evans 2005</a>). </p> </section> <section id="CD010344-sec-0071"> <h3 class="title" id="CD010344-sec-0071">Overall completeness and applicability of evidence</h3> <p>The evidence for acute pharmacological management of hyperkalaemia is strikingly incomplete. For example, sodium polystyrene sulphonate and other potassium‐binding resins are routinely used to decrease serum potassium despite a lack of RCTs evaluating these medications in hyperkalaemic patients. Similarly, IV calcium is commonly administered to patients with hyperkalaemia for membrane stabilization despite the absence of any clinical studies to support its use. This shortage of prospective, clinical outcome data likely relates to ethical concerns associated with using endpoints such as cardiac arrhythmia or death. Clinicians cannot justify placebo‐controlled studies when available observational data suggests that patient outcomes are poor when hyperkalaemia is left untreated. </p> </section> <section id="CD010344-sec-0072"> <h3 class="title" id="CD010344-sec-0072">Quality of the evidence</h3> <p>The quality of the evidence evaluating pharmacological therapies for reducing serum potassium is generally poor. There was insufficient reporting of allocation procedures, blinding and statistical techniques in nearly all studies. However, the outcome evaluated by most studies (serum potassium) is objective so these methodological short‐comings may not have biased the results to any great extent. <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> excluded patients who did not respond to therapy, thus biasing the results significantly. The majority of studies were very small (10, 12, 68, 34, 30, 17, and 70 for a total of only 241 patients) which may limit the accuracy of the results. Most of the studies did not report standard deviations for all of their results and this greatly limited our ability to compare treatments. </p> </section> <section id="CD010344-sec-0073"> <h3 class="title" id="CD010344-sec-0073">Potential biases in the review process</h3> <p>The articles were reviewed by three independent authors, none of whom have any conflict of interest to declare. </p> <p>We attempted to contact all of the authors of the studies included in the review for additional information. We received additional information on the study methodology and results for the studies <a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> and <a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a>. Unfortunately the author was not able to provide individual patient data or additional results of paired analysis statistical tests which would have allowed us to include paired statistical data in the review. The lack of paired data limits the power of the analyses. We did receive a response from the authors of <a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> but they were unable to provide us with any further statistical information regarding the study results. We did not receive responses concerning <a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>, <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a>, <a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a> or <a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>. Because we included all RCTs regardless of methodology, we included <a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> despite highly biased results due to the authors excluding treatment non‐responders. Despite applying a search strategy that was designed to identify both published and unpublished studies, we were unable to include any unpublished studies. </p> </section> <section id="CD010344-sec-0074"> <h3 class="title" id="CD010344-sec-0074">Agreements and disagreements with other studies or reviews</h3> <p>This review is a revision of the previous Cochrane systematic review. The results, where overlap exists, are consistent between the reviews (<a href="./references#CD010344-bbs2-0037" title="MahoneyBA , SmithWA , LoD , TsoiK , TonelliM , ClaseC . Emergency interventions for hyperkalaemia. Cochrane Database of Systematic Reviews2005, Issue 2. [DOI: 10.1002/14651858.CD003235.pub2] ">Clase 2005</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD010344-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram" data-id="CD010344-fig-0001" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies" data-id="CD010344-fig-0002" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study" data-id="CD010344-fig-0003" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 10 mg nebulised salbutamol versus placebo, Outcome 1 Serum potassium." data-id="CD010344-fig-0004" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 10 mg nebulised salbutamol versus placebo, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 20 mg nebulised salbutamol versus placebo, Outcome 1 Serum potassium." data-id="CD010344-fig-0005" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 20 mg nebulised salbutamol versus placebo, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 10 mg versus 20 mg nebulised salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0006" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 10 mg versus 20 mg nebulised salbutamol, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 0.5 mg IV versus 10 mg nebulised salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0007" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 0.5 mg IV versus 10 mg nebulised salbutamol, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 IV salbutamol versus IV insulin‐dextrose, Outcome 1 Serum potassium." data-id="CD010344-fig-0008" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 IV salbutamol versus IV insulin‐dextrose, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 20 mg nebulised salbutamol versus IV insulin‐dextrose, Outcome 1 Serum potassium." data-id="CD010344-fig-0009" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 20 mg nebulised salbutamol versus IV insulin‐dextrose, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 20 mg nebulised salbutamol versus 20 mg nebulised salbutamol plus IV insulin‐dextrose, Outcome 1 Serum potassium." data-id="CD010344-fig-0010" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 20 mg nebulised salbutamol versus 20 mg nebulised salbutamol plus IV insulin‐dextrose, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 IV salbutamol versus IV salbutamol plus IV insulin‐dextrose, Outcome 1 Serum potassium." data-id="CD010344-fig-0011" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 IV salbutamol versus IV salbutamol plus IV insulin‐dextrose, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 IV salbutamol versus IV insulin‐dextrose plus sodium bicarbonate, Outcome 1 Serum potassium." data-id="CD010344-fig-0012" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 IV salbutamol versus IV insulin‐dextrose plus sodium bicarbonate, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 IV salbutamol versus IV salbutamol plus IV insulin‐dextrose plus IV sodium bicarbonate, Outcome 1 Serum potassium." data-id="CD010344-fig-0013" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 IV salbutamol versus IV salbutamol plus IV insulin‐dextrose plus IV sodium bicarbonate, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 IV Insulin‐dextrose versus IV sodium bicarbonate, Outcome 1 Serum potassium." data-id="CD010344-fig-0014" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 IV Insulin‐dextrose versus IV sodium bicarbonate, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 IV insulin‐dextrose versus IV aminophylline, Outcome 1 Serum potassium." data-id="CD010344-fig-0015" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 IV insulin‐dextrose versus IV aminophylline, Outcome 1 Serum potassium.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 IV insulin‐dextrose versus IV insulin‐dextrose plus 20 mg nebulised salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0016" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 IV insulin‐dextrose versus IV insulin‐dextrose plus 20 mg nebulised salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 IV insulin‐dextrose versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0017" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 IV insulin‐dextrose versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate, Outcome 1 Serum potassium." data-id="CD010344-fig-0018" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 IV insulin‐dextrose versus IV salbutamol IV plus IV sodium bicarbonate, Outcome 1 Serum potassium." data-id="CD010344-fig-0019" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 IV insulin‐dextrose versus IV salbutamol IV plus IV sodium bicarbonate, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0020" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 IV sodium bicarbonate versus IV salbutamol plus IV sodium bicarbonate, Outcome 1 Serum potassium." data-id="CD010344-fig-0021" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 IV sodium bicarbonate versus IV salbutamol plus IV sodium bicarbonate, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0022" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 IV insulin‐dextrose plus sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0023" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 IV insulin‐dextrose plus sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 IV insulin‐dextrose plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0024" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 IV insulin‐dextrose plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 IV salbutamol plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0025" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 IV salbutamol plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD010344-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/urn:x-wiley:14651858:media:CD010344:CD010344-CMP-023-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_t/tCD010344-CMP-023-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 IV insulin‐dextrose plus IV salbutamol versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol, Outcome 1 Serum potassium." data-id="CD010344-fig-0026" src="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-023-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23 IV insulin‐dextrose plus IV salbutamol versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol, Outcome 1 Serum potassium. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/media/CDSR/CD010344/image_n/nCD010344-CMP-023-01.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD010344-tbl-0001"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Side effects and adverse events</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Study ID</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment group(s)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Control group</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0001" title="AllonM , CopkneyC , DunlayRW . Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]. Kidney International1989;35(1):238. [CENTRAL: CN‐00583886] AllonM , DunlayR , CopkneyC . Nebulized albuterol for acute hyperkalemia in patients on hemodialysis. Annals of Internal Medicine1989;110(6):426‐9. [MEDLINE: 2919849] ">Allon 1989</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One patient receiving salbutamol nebules experienced mild anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0002" title="AllonM , CopkneyC . Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients. Kidney International1990;38(5):869‐72. [MEDLINE: 2266671] ">Allon 1990</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nine patients receiving insulin‐dextrose experienced hypoglycaemia</p> <p>Two patients receiving insulin‐dextrose combined with salbutamol nebules experienced hypoglycaemia </p> <p>Patients receiving insulin‐dextrose combined with salbutamol nebules had a significant increase in heart rate </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15 patients receiving salbutamol IV and two patients receiving salbutamol nebules experienced minor adverse effects (headache, dizziness, palpations) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0004" title="LiouHH , ChiangSS , WuSC , YangWC , HuangTP . Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure. Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]1994;53(5):276‐81. [MEDLINE: 8039040] ">Liou 1994</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Three patients receiving salbutamol IV experienced adverse effects (transient tachycardia, palpation, mild chest tightness) </p> <p>One patient receiving salbutamol nebules experienced mild, transient dizziness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0005" title="MahajanSK , ManglaM , KishoreK . Comparison of aminophylline and insulin‐dextrose infusions in acute therapy of hyperkalemia in end‐stage renal disease patients. Journal of the Association of Physicians of India2001;49:1082‐5. [MEDLINE: 11868861] ">Mahajan 2001</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>One patient receiving insulin‐dextrose experienced hypoglycaemia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Patients receiving salbutamol MDI had an increase in heart rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>None reported</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adverse effects not reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No control group</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="3"> <div class="table-footnote"> <p>IV ‐ intravenous; MDI ‐ metered‐dose inhaler</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Side effects and adverse events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD010344-tbl-0002"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Serum potassium (mmol/L)</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign=""> <p><b>Comparisons<br/> (study ID)</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="9" rowspan="1" valign=""> <p><b>Time points (mean ± SD* (number of participants))</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>1 minute</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>3 minutes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>5 minutes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>10 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>30 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>60 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>120 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>240 minutes</b> </p> </td> <td align="center" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>480 minutes</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (0.5 mg IV)</p> <p>(<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.76 ± 0.26 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.70 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (10 mg nebulised)</p> <p>(<a href="./references#CD010344-bbs2-0003" title="BalanzarioJM , NuevoJJ , GaetaDE , RiveraLL , AyalaGV , LopezLR . Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure [Efecto del salbutamol intravenoso vs salbutamol en micronebulizador en la hipercaliemia por insuficiencia renal cronica]. Medicina Interna de Mexico2003;19(4):202‐5. [EMBASE: 2007509847] ">Balanzario 2003</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.69 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.71 ± 0.11 (34)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (MDI)</p> <p>(<a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.55 ± 0.17 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 ± 0.16 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.33 ± 0.17 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.22 ± 0.16 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.17 ± 0.17 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1 ± 0.18 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Placebo</p> <p>(<a href="./references#CD010344-bbs2-0006" title="MandelbergA , KrupnikZ , HouriS , SmetanaS , GiladE , MatasZ , et al. Salbutamol metered‐dose inhaler with spacer for hyperkalemia: how fast? How safe?. Chest1999;115(3):617‐22. [MEDLINE: 10084465] ">Mandelberg 1999</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.42 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.44 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.43 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.44 (17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insulin dextrose (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.85 ± 0.47 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.44 ± 0.66 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.90 ± 0.45 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.61 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.41 (9)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.80 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.03 ± 0.41 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.90 ± 0.56 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.65 (8)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.48 (7)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Sodium bicarbonate (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.47 ± 0.31 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.57 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.6 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.48 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insulin‐dextrose IV plus sodium bicarbonate (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.85 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.17 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.19 ± 0.5 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.99 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.71 (10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Insulin‐dextrose IV plus salbutamol (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.09 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.39 ± 0.66 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.18 ± 0.69 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.85 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.62 (10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol IV plus sodium bicarbonate (IV)</p> <p>(<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.71 ± 0.43 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.81 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.72 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.57 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐0.36 (10)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Salbutamol IV plus sodium bicarbonate (IV)</p> <p>plus Insulin‐dextrose IV (<a href="./references#CD010344-bbs2-0007" title="NgugiNN , McLigeiyoSO , KayimaJK . Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches. East African Medical Journal1997;74(8):503‐9. [MEDLINE: 9487416] ">Ngugi 1997</a>) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐‐</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.2 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.55 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.69 ± 0.54 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.29 (10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐1.05 (9)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p>* if provided; ‐‐ not reported</p> <p>Iv ‐ intravenous; MDI ‐ metered‐dose inhaler</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Serum potassium (mmol/L)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/full#CD010344-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">10 mg nebulised salbutamol versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 90 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">10 mg nebulised salbutamol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">20 mg nebulised salbutamol versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 90 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">20 mg nebulised salbutamol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">10 mg versus 20 mg nebulised salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 90 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">10 mg versus 20 mg nebulised salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">0.5 mg IV versus 10 mg nebulised salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 0 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 10 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 20 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6 90 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.8 180 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">0.5 mg IV versus 10 mg nebulised salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">IV salbutamol versus IV insulin‐dextrose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">IV salbutamol versus IV insulin‐dextrose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">20 mg nebulised salbutamol versus IV insulin‐dextrose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 15 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 45 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">20 mg nebulised salbutamol versus IV insulin‐dextrose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">20 mg nebulised salbutamol versus 20 mg nebulised salbutamol plus IV insulin‐dextrose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 15 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 45 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">20 mg nebulised salbutamol versus 20 mg nebulised salbutamol plus IV insulin‐dextrose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">IV salbutamol versus IV salbutamol plus IV insulin‐dextrose</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">IV salbutamol versus IV salbutamol plus IV insulin‐dextrose</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">IV salbutamol versus IV insulin‐dextrose plus sodium bicarbonate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">IV salbutamol versus IV insulin‐dextrose plus sodium bicarbonate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">IV salbutamol versus IV salbutamol plus IV insulin‐dextrose plus IV sodium bicarbonate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">IV salbutamol versus IV salbutamol plus IV insulin‐dextrose plus IV sodium bicarbonate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">IV Insulin‐dextrose versus IV sodium bicarbonate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">IV Insulin‐dextrose versus IV sodium bicarbonate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">IV insulin‐dextrose versus IV aminophylline</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 180 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 360 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">IV insulin‐dextrose versus IV aminophylline</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus 20 mg nebulised salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 15 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 45 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus 20 mg nebulised salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 60 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">IV insulin‐dextrose versus IV salbutamol IV plus IV sodium bicarbonate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">IV insulin‐dextrose versus IV salbutamol IV plus IV sodium bicarbonate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">IV insulin‐dextrose versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">IV sodium bicarbonate versus IV salbutamol plus IV sodium bicarbonate</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">IV sodium bicarbonate versus IV salbutamol plus IV sodium bicarbonate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">IV insulin‐dextrose plus sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">IV insulin‐dextrose plus sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">IV insulin‐dextrose plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">IV insulin‐dextrose plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">IV salbutamol plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 30 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">IV salbutamol plus IV sodium bicarbonate versus IV insulin‐dextrose plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD010344-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">IV insulin‐dextrose plus IV salbutamol versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Serum potassium <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 120 minutes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">IV insulin‐dextrose plus IV salbutamol versus IV insulin‐dextrose plus IV sodium bicarbonate plus IV salbutamol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD010344.pub2/references#CD010344-tbl-0025">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD010344.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD010344-note-0002">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD010344-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD010344-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738735355000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738735355000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773978000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774074000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739774000000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010344\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010344\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010344\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD010344\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD010344\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738735355000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uYcNEb5O&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010344.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD010344.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD010344.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD010344.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD010344.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726926576"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010344.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726926579"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD010344.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e9f91fae2f480',t:'MTc0MDcyNjkyNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 